Matches in Wikidata for { <http://www.wikidata.org/entity/Q100476308> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q100476308 description "artículu científicu espublizáu n'ochobre de 2020" @default.
- Q100476308 description "scientific article published on 07 October 2020" @default.
- Q100476308 description "wetenschappelijk artikel" @default.
- Q100476308 description "наукова стаття, опублікована 7 жовтня 2020" @default.
- Q100476308 name "A Phase 3 Randomized Clinical Trial using Once-Weekly GLP-1 Receptor Agonist in Adolescents and Young Adults with Hypothalamic Obesity" @default.
- Q100476308 name "A Phase 3 Randomized Clinical Trial using Once-Weekly GLP-1 Receptor Agonist in Adolescents and Young Adults with Hypothalamic Obesity" @default.
- Q100476308 name "A Phase 3 Randomized Clinical Trial using Once-Weekly GLP-1 Receptor Agonist in Adolescents and Young Adults with Hypothalamic Obesity" @default.
- Q100476308 type Item @default.
- Q100476308 label "A Phase 3 Randomized Clinical Trial using Once-Weekly GLP-1 Receptor Agonist in Adolescents and Young Adults with Hypothalamic Obesity" @default.
- Q100476308 label "A Phase 3 Randomized Clinical Trial using Once-Weekly GLP-1 Receptor Agonist in Adolescents and Young Adults with Hypothalamic Obesity" @default.
- Q100476308 label "A Phase 3 Randomized Clinical Trial using Once-Weekly GLP-1 Receptor Agonist in Adolescents and Young Adults with Hypothalamic Obesity" @default.
- Q100476308 prefLabel "A Phase 3 Randomized Clinical Trial using Once-Weekly GLP-1 Receptor Agonist in Adolescents and Young Adults with Hypothalamic Obesity" @default.
- Q100476308 prefLabel "A Phase 3 Randomized Clinical Trial using Once-Weekly GLP-1 Receptor Agonist in Adolescents and Young Adults with Hypothalamic Obesity" @default.
- Q100476308 prefLabel "A Phase 3 Randomized Clinical Trial using Once-Weekly GLP-1 Receptor Agonist in Adolescents and Young Adults with Hypothalamic Obesity" @default.
- Q100476308 P1433 Q100476308-6797DC23-BBAA-471D-8284-E79C4A18A0B5 @default.
- Q100476308 P1476 Q100476308-CD624DE1-519F-4D0C-8094-017C059F9101 @default.
- Q100476308 P2093 Q100476308-2223B4EB-3218-42E9-9F4A-610910E474FC @default.
- Q100476308 P2093 Q100476308-303741FC-88E9-4A6B-82B3-4EAFA2E67697 @default.
- Q100476308 P2093 Q100476308-34970EF9-71BD-4AE2-808E-5B3A30F49B46 @default.
- Q100476308 P2093 Q100476308-59C165A9-BC9E-470E-B1F0-B73B2A851362 @default.
- Q100476308 P2093 Q100476308-A2BAF48A-DD17-4143-94E1-49A571C4E440 @default.
- Q100476308 P2093 Q100476308-B447AAF2-2B5D-4751-9276-DF150CFB9BC1 @default.
- Q100476308 P2860 Q100476308-B51C0B95-FC39-4126-802A-B0666BD2DCDE @default.
- Q100476308 P31 Q100476308-B6ECCE89-13FC-44DE-9440-62EA6B299D42 @default.
- Q100476308 P356 Q100476308-FB236C0D-5248-4A00-86F9-F601957B38EE @default.
- Q100476308 P50 Q100476308-BEDDF53B-0C25-432F-9553-D036C258C220 @default.
- Q100476308 P577 Q100476308-72B3AF07-14C5-43D9-AE8A-53B9AC5CB069 @default.
- Q100476308 P698 Q100476308-C268A3FD-D67F-4770-9802-DC922835123B @default.
- Q100476308 P932 Q100476308-36353C79-8CF1-4607-B03B-D338D0B44B09 @default.
- Q100476308 P356 DOM.14224 @default.
- Q100476308 P698 33026160 @default.
- Q100476308 P1433 Q5270109 @default.
- Q100476308 P1476 "A Phase 3 Randomized Clinical Trial using Once-Weekly GLP-1 Receptor Agonist in Adolescents and Young Adults with Hypothalamic Obesity" @default.
- Q100476308 P2093 "Ashley H Shoemaker" @default.
- Q100476308 P2093 "Clinton Elfers" @default.
- Q100476308 P2093 "Francisco A Perez" @default.
- Q100476308 P2093 "Jack A Yanovski" @default.
- Q100476308 P2093 "Kathryn B Whitlock" @default.
- Q100476308 P2093 "M Jennifer Abuzzahab" @default.
- Q100476308 P2860 Q42176081 @default.
- Q100476308 P31 Q13442814 @default.
- Q100476308 P356 "10.1111/DOM.14224" @default.
- Q100476308 P50 Q89690672 @default.
- Q100476308 P577 "2020-10-07T00:00:00Z" @default.
- Q100476308 P698 "33026160" @default.
- Q100476308 P932 "7821019" @default.